Page last updated: 2024-09-04

ruboxistaurin and Left Ventricular Hypertrophy

ruboxistaurin has been researched along with Left Ventricular Hypertrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, X; Irwin, MG; Lei, S; Liu, Y; Mao, X; Vanhoutte, PM; Wang, T; Wong, GT; Xia, Z1

Other Studies

1 other study(ies) available for ruboxistaurin and Left Ventricular Hypertrophy

ArticleYear
PKCĪ² inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
    Clinical science (London, England : 1979), 2012, Volume: 122, Issue:4

    Topics: Acetylcysteine; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Dinoprost; Drug Evaluation, Preclinical; Enzyme Activation; Free Radical Scavengers; Hypertrophy, Left Ventricular; Indoles; Isoprostanes; Male; Maleimides; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; Superoxides; Ultrasonography

2012